Keith Pietropaolo
Chief Tech/Sci/R&D Officer at ATEA PHARMACEUTICALS, INC.
Profile
Keith Pietropaolo is currently working as a Senior Vice President-Clinical Operations at Atea Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior Director-Clinical Operations at Sideris Pharmaceuticals, Inc. from 2014 to 2015, and at Idenix Pharmaceuticals LLC from 2003 to 2014.
In 2016, he briefly worked as a Senior Director-Clinical Operations at Alnylam Pharmaceuticals, Inc. Additionally, Mr. Pietropaolo has worked as a Principal at Boston Biostatistics, Inc. Mr. Pietropaolo completed his undergraduate degree at Boston College.
Keith Pietropaolo active positions
Companies | Position | Start |
---|---|---|
ATEA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Keith Pietropaolo
Companies | Position | End |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2016 |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Chief Operating Officer | 01/01/2015 |
IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01/04/2014 |
Boston Biostatistics, Inc. | Corporate Officer/Principal | - |
Training of Keith Pietropaolo
Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ATEA PHARMACEUTICALS, INC. | Health Technology |
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
Boston Biostatistics, Inc. |
- Stock Market
- Insiders
- Keith Pietropaolo